4//SEC Filing
Tourangeau Greg 4
Accession 0000950170-23-021245
CIK 0001680581other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:12 PM ET
Size
4.8 KB
Accession
0000950170-23-021245
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Sale
Common Stock
2023-05-10$3.31/sh−210$695→ 15,992 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001916566
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:12 PM ET
- Size
- 4.8 KB